Skip to search formSkip to main contentSkip to account menu

CO-101

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

CP 4126

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours
AbstractBackground CP-4126 (gemcitabine elaidate, previously CO-101) is a lipid–drug conjugate of gemcitabine designed to… 
2013
2013
Randomized multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) and a prospective evaluation of the of the association between…
4007 Background: Gemcitabine requires membrane transporter proteins to cross the cell membrane. Low expression of the human… 
2013
2013
A Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO‐101 in Patients With Advanced Solid Tumors
s). 2011;29:TPS144. 13. Ikdahl T, Dueland S, Hendlisz A, et al. Phase II study of CP‐4126, a gemcitabine‐lipid conjugate, in… 
2012
2012
581 An Adaptive, 2-stage, Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO-101 in Patients with Advanced Solid Tumors
2006
2006
Изучение фармакокинетики препарата Co-101 с использованием радионуклидного метода
The pharmacokinetics of a new medicinal preparation Co-101 in rats was studied by radionuclide techniques using a radioactive… 
2006
2006
Pharmacokinetics of the new complex preparation Co-101 studied by the radionuclide method
The pharmacokinetics of a new cobalt-containing complex medicinal preparation (Co-101) in rats was studied by a radionuclide… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)